535-0901-00L  From A to Z in Drug Discovery and Development

SemesterFrühjahrssemester 2021
DozierendeJ. Hall, K.‑H. Altmann, M. Detmar, R. Schibli, H. U. Zeilhofer
Periodizitätjährlich wiederkehrende Veranstaltung
LehrveranstaltungFindet dieses Semester nicht statt.
LehrspracheEnglisch



Lehrveranstaltungen

NummerTitelUmfangDozierende
535-0901-00 SFrom A to Z in Drug Discovery and Development
Findet dieses Semester nicht statt.
The next course will take place in autumn semester 2021.
2 Std.J. Hall, K.‑H. Altmann, M. Detmar, R. Schibli, H. U. Zeilhofer

Katalogdaten

KurzbeschreibungThe lecture series takes place at the ETH Hönggerberg and covers a variety of major activities involved in drug discovery: selecting drug targets, technologies used in drug discovery, small, medium and large drugs, objectives of the medicinal chemist, assessing drug safety, principles of personalized medicine, designing clinical trials, how intellectual property is protected, as well as others.
LernzielThe objective of the course is to gain a global understanding of most of the important phases in the discovery and development of modern synthetic and biological drugs, from the first activities to clinical trials. The lecture is intended for students that have an interest in the area and/or may consider a career working in drug discovery. This lecture course complements knowledge and experience gained in the research project performed by the PhD student.
InhaltFifteen two hour lectures for life-science PhD students, given by experts from the ETH, UZH, USZ and the pharmaceutical industry.
Introduction to the modern drug discovery process - Principles of drug pharmacokinetics and drug metabolism - Computer sciences in drug discovery - Drug targets - In vitro methods in drug discovery - Natural products in drug discovery - Medicinal chemistry: Chemical lead selection/optimization - Nucleic acid-based drugs - Antibodies and therapeutic proteins: Targets and drugs - In vivo molecular imaging in drug discovery - Personalized medicine in drug discovery and development - Drug formulation: Key development consideration, Current new APIs challenges and FDA rising standards - Preclinical safety, adverse drug events and drug-drug interactions - Clinical development steps including trial design - Intellectual property in drug discovery and development
SkriptScripts to be uploaded into ILIAS
LiteraturTo be distributed during the lecture
Voraussetzungen / BesonderesFormally none, but a basic understanding in biochemistry, physiology and chemistry is highly desirable as it will certainly help to get the most from the lectures.

Leistungskontrolle

Information zur Leistungskontrolle (gültig bis die Lerneinheit neu gelesen wird)
Leistungskontrolle als Semesterkurs
ECTS Kreditpunkte2 KP
PrüfendeJ. Hall, K.-H. Altmann, J. Baumgartner, M. Detmar, D. Neri, R. Schibli, H. U. Zeilhofer
Formunbenotete Semesterleistung
PrüfungsspracheEnglisch
RepetitionRepetition nur nach erneuter Belegung der Lerneinheit möglich.

Lernmaterialien

Keine öffentlichen Lernmaterialien verfügbar.
Es werden nur die öffentlichen Lernmaterialien aufgeführt.

Gruppen

Keine Informationen zu Gruppen vorhanden.

Einschränkungen

Keine zusätzlichen Belegungseinschränkungen vorhanden.

Angeboten in

StudiengangBereichTyp
Doktorat Departement Chemie und Angewandte BiowissenschaftenDoktoratsausbildung in Pharmazeutischen WissenschaftenZInformation